#Tuberculosis: We conducted the first within-trial cost-utility analysis of 6-month BPaL-based regimens (bedaquiline, pretomanid, and linezolid) for rifampin-resistant #TB.
More about our findings below ⬇️ #IDSky #AidSky #MedSky
More about our findings below ⬇️ #IDSky #AidSky #MedSky
Comments
- Cut costs for both providers and patients
- Enhance treatment
- Reduce pill burden
- Free up critical resources within health systems
https://t.co/kZtXFtZqdt
https://kabiragorillasafaris.com/gorilla-trekking-from-entebbe
#Email: [email protected]
#Luxembourg #Singapore #Ireland #Qatar #Bermuda #Norway #UAE #Switzerland #USA #Brunei #HongKong #Denmark #Netherlands #Australia #Finland #Canada